69.16
1.13 (1.66%)
| Previous Close | 68.03 |
| Open | 67.27 |
| Volume | 354,428 |
| Avg. Volume (3M) | 420,778 |
| Market Cap | 2,009,642,240 |
| Price / Sales | 10.67 |
| Price / Book | 123.05 |
| 52 Weeks Range | |
| Earnings Date | 5 Nov 2025 |
| Profit Margin | -52.34% |
| Operating Margin (TTM) | -40.96% |
| Diluted EPS (TTM) | -3.12 |
| Quarterly Revenue Growth (YOY) | 11.30% |
| Total Debt/Equity (MRQ) | 585.48% |
| Current Ratio (MRQ) | 3.36 |
| Operating Cash Flow (TTM) | -68.09 M |
| Levered Free Cash Flow (TTM) | -44.94 M |
| Return on Assets (TTM) | -11.43% |
| Return on Equity (TTM) | -186.68% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Medical Devices (US) | Mixed | Mixed |
| Medical Devices (Global) | Mixed | Mixed | |
| Stock | Establishment Labs Holdings Inc | Bullish | Bullish |
AIStockmoo Score
| Analyst Consensus | 4.0 |
| Insider Activity | NA |
| Price Volatility | -3.0 |
| Technical Moving Averages | 0.0 |
| Technical Oscillators | 4.0 |
| Average | 1.25 |
|
Establishment Labs Holdings Inc is a medical technology company engaged in offering medical devices and aesthetic products. It is involved in the designing, manufacturing, and marketing silicone-filled breast and body shaping implants. The company markets its products under Motiva implants Brand. It distributes its products to medical distributors; and physicians, hospitals, and clinics in the form of direct sales. Its geographical segments are Europe, Latin America, Asia-Pacific/Middle East, and Others. |
|
| Sector | Healthcare |
| Industry | Medical Devices |
| Investment Style | Small Growth |
| % Held by Insiders | 10.75% |
| % Held by Institutions | 106.06% |
Ownership
| Name | Date | Shares Held |
|---|---|---|
| Jw Asset Management, Llc | 30 Sep 2025 | 3,082,785 |
| Mudita Advisors Llp | 30 Sep 2025 | 686,764 |
| 52 Weeks Range | ||
| Price Target Range | ||
| High | 85.00 (Mizuho, 22.90%) | Buy |
| Median | 72.00 (4.11%) | |
| Low | 70.00 (Needham, 1.22%) | Buy |
| Average | 75.80 (9.60%) | |
| Total | 5 Buy | |
| Avg. Price @ Call | 64.73 | |
| Firm | Date | Target Price | Call | Price @ Call |
|---|---|---|---|---|
| BTIG | 14 Nov 2025 | 81.00 (17.12%) | Buy | 63.99 |
| 05 Nov 2025 | 70.00 (1.21%) | Buy | 60.51 | |
| Canaccord Genuity | 06 Nov 2025 | 72.00 (4.11%) | Buy | 64.91 |
| JP Morgan | 06 Nov 2025 | 71.00 (2.66%) | Buy | 64.91 |
| Mizuho | 06 Nov 2025 | 85.00 (22.90%) | Buy | 64.91 |
| Needham | 06 Nov 2025 | 70.00 (1.21%) | Buy | 64.91 |
No data within this time range.
| Date | Type | Details |
|---|---|---|
| 07 Nov 2025 | Announcement | Establishment Labs to Present at Jefferies London Healthcare Conference |
| 05 Nov 2025 | Announcement | Establishment Labs Reports Third Quarter 2025 Financial Results |
| 22 Oct 2025 | Announcement | Establishment Labs to Announce Third Quarter 2025 Financial Results on November 5 |
| 14 Oct 2025 | Announcement | Establishment Labs Notes Publication of Mia Femtech 3-Year Prospective Study Results in Aesthetic Surgery Journal |
| 09 Oct 2025 | Announcement | Establishment Labs Publishes 15 Years of Motiva Data in 2025 Post-Market Surveillance Report |
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2025 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |